TNL Mediagene announced its unaudited financial results for the six months ended June 30, 2025 (H1 2025) on October 7, 2025. Total revenues increased by 5.7% to $21.8 million compared to $20.6 million in H1 2024.
Gross profit declined 14.6% to $7.0 million (32.1% margin) from $8.2 million (39.7% margin) in H1 2024. Adjusted EBITDA declined to a loss of $3.2 million from a loss of $1.4 million in H1 2024, reflecting $1.8 million in newly incurred public company costs.
Net loss narrowed 27.2% to $4.3 million from $5.9 million in H1 2024, primarily due to a financial liability valuation gain. Cash and cash equivalents were $1.6 million as of June 30, 2025, down from $3.6 million at year-end 2024.
The company reported net cash used in operating activities of $1.8 million for H1 2025. The audited consolidated financial statements for FY2024 and unaudited H1 2025 results include disclosure regarding substantial doubt about the company's ability to continue as a going concern, requiring additional financing by Q2 2026.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.